US2012065374A1PendingUtilityA1
Dendritic cell co-stimulatory molecules
Est. expiryApr 28, 2020(expired)· nominal 20-yr term from priority
C07K 14/70532C07K 16/2827A61K 39/39558A61K 2039/57A61K 2039/55516C07K 2319/00A61P 37/04C07K 2319/30A61K 2039/505A61P 37/02A61K 38/00A61P 37/06A61P 35/00A61K 40/46A61K 40/32A61K 40/11A61K 2239/38A61P 31/00C12N 15/11
58
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A novel costimulatory protein molecule, B7-DC, which is a member of the B7 family, is described as is DNA coding therefor and expression vectors comprising this DNA. B7-DC protein, fragments, fusion polypeptides/proteins and other functional derivatives, and transformed cells expressing B7-DC are useful in vaccine compositions and methods. Compositions and methods are disclosed for inducing potent T cell mediated responses that can be harnessed for anti-tumor and anti-viral immunity.
Claims
exact text as granted — not AI-modified1 .- 31 . (canceled)
32 . A polypeptide that is selectively expressed on dendritic cells as compared to activated macrophages and has the following functional properties:
(a) binds to a binding partner on T cells; and (b) costimulates T cells to proliferate and/or to produce and secrete cytokines.
33 .- 120 . (canceled)Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.